ELRIG Research & Innovation
This event will discuss how emerging biology and cutting-edge technologies are pioneering the medicines of tomorrow. Bringing together scientists, researchers and entrepreneurs with bold ideas to serve our shared ambitions in creating the next generation of therapeutics to cure more patients around the world.
This event will discuss how emerging biology and cutting-edge technologies are pioneering the medicines of tomorrow. Bringing together scientists, researchers and entrepreneurs with bold ideas to serve our shared ambitions in creating the next generation of therapeutics to cure more patients around the world.
We are sponsors at this event!
Come and visit our team at our booth and meet our team to discuss how bit.bio offers partnering opportunities that affords access to the most relevant parental human cell types and corresponding disease models. These models are physiologically relevant and highly characterised, offering predictive, in vitro, human cells for early drug discovery, phenotypic screening, and high-content imaging applications.
Listen to our talk 'How can drug discovery reduce its reliance on animal models? Advancements in iPSC-derived human cells to more accurately recapitulate human biology in vitro' by Dominic Hussey |Territorial Head, EMEA Sales:
Day: Wednesday 20th March
Time: 10.10 am
Location: Theatre B (first floor)
Arrange a meeting